56: Treatment of Multiple Myeloma

Jul 8, 2016 by in ONCOLOGY Comments Off on 56: Treatment of Multiple Myeloma

Treatment of Multiple Myeloma Cindy Varga, Claudia Paba Prada, Kenneth Anderson, and Paul Richardson Dana-Farber Cancer Institute, Boston, MA, USA Prognostic Markers Introduction Multiple myeloma is a heterogeneous disease with…

read more

26: Primary Myelofibrosis

Jul 8, 2016 by in ONCOLOGY Comments Off on 26: Primary Myelofibrosis

Primary Myelofibrosis Ayalew Tefferi Mayo Clinic, Rochester, MN, USA Introduction Primary myelofibrosis (PMF) is listed under the World Health Organization (WHO) classification category of myeloproliferative neoplasms (MPNs). The operational subcategory…

read more

55: Risk Stratification and Response Assessment in Multiple Myeloma and Waldenström’s Macroglobulinemia

Jul 8, 2016 by in ONCOLOGY Comments Off on 55: Risk Stratification and Response Assessment in Multiple Myeloma and Waldenström’s Macroglobulinemia

Risk Stratification and Response Assessment in Multiple Myeloma and Waldenström’s Macroglobulinemia Silvia Gentili1 and Sagar Lonial2 1Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Ancona, Italy 2The Winship Cancer Institute of Emory…

read more

47: HIV-Associated Lymphoma

Jul 8, 2016 by in ONCOLOGY Comments Off on 47: HIV-Associated Lymphoma

HIV-Associated Lymphoma Kieron Dunleavy National Cancer Institute, Bethesda, MD, USA 1.  What are the most important etiological factors for the development of HIV-associated lymphoma? The pathogenesis of HIV-associated lymphoma is complex…

read more

45: Gray Zone Lymphoma

Jul 8, 2016 by in ONCOLOGY Comments Off on 45: Gray Zone Lymphoma

Gray Zone Lymphoma Caron A. Jacobson1 and Ann S. LaCasce2 1Dana-Farber Cancer Institute, Boston, MA, USA 2Dana-Farber/Partners CancerCare, Boston, MA, USA Case study 45.1 A 62-year-old woman presents to the…

read more

44: Burkitt Lymphoma

Jul 8, 2016 by in ONCOLOGY Comments Off on 44: Burkitt Lymphoma

Burkitt Lymphoma Mark Roschewski and Wyndham Wilson National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Case study 44.1 A 55-year-old man presents to the emergency department with the…

read more

43: Primary Mediastinal Large B-Cell Lymphoma

Jul 8, 2016 by in ONCOLOGY Comments Off on 43: Primary Mediastinal Large B-Cell Lymphoma

Primary Mediastinal Large B-Cell Lymphoma Pier Luigi Zinzani Institute of Hematology “Seràgnoli,” University of Bologna, Bologna, Italy Primary mediastinal large B-cell lymphoma (PMLBCL) is a subtype of diffuse large B-cell…

read more

12: Relapsed and Refractory Acute Myeloid Leukemia

Jul 8, 2016 by in ONCOLOGY Comments Off on 12: Relapsed and Refractory Acute Myeloid Leukemia

Relapsed and Refractory Acute Myeloid Leukemia Stefan H. Faderl Hackensack University Medical Center, Hackensack, NJ, USA Case study 12.1 A 54-year-old woman is diagnosed with acute myeloid leukemia (AML). The…

read more
Get Clinical Tree app for offline access